Posts Tagged ‘hep c’
What is Hepatitis?
What is Hepatitis? Hepatitis refers to an inflammation of the liver cells and damage to the liver. There are different types and causes, but the symptoms can be similar. The liver’s functions include detoxifying the blood, storing vitamins, and producing hormones. Hepatitis can disrupt these processes and create severe health problems throughout the body. At…
Read MorePreviously Unforeseen Risk Tarnishes Hep C Wonder Drugs
The improvement in Hepatitis C treatment success marks a dramatic change in the prognosis for most Hepatitis C diagnoses. New direct-acting antiviral drugs boast viral eradication rates in the high 90th percentile, rendering hope that the Hepatitis C virus can be eradicated. Until recently, the only major obstacle surrounding these Hepatitis C medications has been…
Read MoreHepatitis C Disease – Progression and Management
Hepatitis C Disease – Progression and Management After exposure to the hepatitis C virus, the window period before antibodies can be detected using a standard test usually lasts from 2 to 26 weeks. The initial phase of hepatitis C is called acute infection. Acute HCV infection may resolve with spontaneous viral clearance, typically within 2–12 weeks.…
Read MoreWhat Is Hepatitis C Viral Load?
If you’re being treated for hepatitis C virus infection — also called HCV– your doctor is keeping track of your viral load. What is HCV viral load? Why does it matter? WebMD got answers to your most frequently asked questions about hepatitis C and viral load from two experts: Frank Anania, MD, associate professor of…
Read MoreTreating Hep C: Effective but Expensive
Last month, the Food and Drug Administration (FDA) approved another in a series of medicines that have dramatically changed the outlook for those diagnosed with hepatitis C. Epclusa is a single pill taken once a day for 12 weeks. It is the first drug to clear all six strains of the virus in up to…
Read MoreAnother study confirms detrimental effects of delaying hepatitis C treatment
Another study confirms detrimental effects of delaying hepatitis C treatment Liz Highleyman Produced in collaboration with hivandhepatitis.com Published: 05 May 2015 Deferring antiviral therapy for hepatitis C until a person progresses to advanced liver disease has clear drawbacks including lower treatment effectiveness and an increased risk of clinical events and death, according to a study…
Read MoreHepatitis C Epidemic in Africa
Hepatitis C Epidemic in Africa The epidemic levels of Hepatitis C virus (HCV) prevalence in Africa is considered one of the most serious health challenges facing African nations by the World Health Organization (WHO). According to Dr. Peter Beyer, Essential Medicines Advisor at WHO, the greatest challenges to fighting HCV in Africa are drug access…
Read More7 Ways Hepatitis C Affects Women Differently than Men
7 Ways Hepatitis C Affects Women Differently than Men Although the virus itself does not discriminate against gender, these seven differences between men and women with Hepatitis C are worth reviewing. First discovered as a contagious virus in 1989, Hepatitis C currently infects an estimated four million Americans. While this highly transmissible virus does not…
Read MoreHope, love and new treatment help overcome Hepatitis C
Hope, love and new treatment help overcome Hepatitis C Barry Morrow diagnosed with disease in 2005 CLARKSVILLE, TENN. — In the United States today, there are approximately 3.2 million citizens living with Hepatitis C, a contagious liver disease spread through blood contact. Many victims remain unaware that they carry this “silent killer,” which can remain…
Read MoreLow uptake of HCV treatment in England will lead to substantial disease burden by 2035
Low uptake of HCV treatment in England will lead to substantial disease burden by 2035 Michael Carter Published: 13 June 2014 Only 3% of patients with chronic hepatitis C virus (HCV) are treated for their infection each year in England, according to research published in the Journal of Hepatology. The current uptake of treatment was…
Read More